Literature DB >> 20587288

Study of Dural Arteriovenous Fistula Drains into Leptomeningeal Vein without Sinus Interposition.

T Kawaguchi1, M Nakatani, T Kawano.   

Abstract

SUMMARY: We evaluated dural arteriovenous fistulas (DAVF) drains into leptomeningeal vein (LMV) without the venous sinus interposition. This type of DAVF contained the extra-sinusal type DAVF and the DAVF with so-called pure leptomeningeal venous drainage (PLMVD).We studied 15 patients with DAVF that flows into LMVD without passing into the sinus. The subjects were 5 patients with DAVF in the anterior cranial fossa, 2 with DAVF in the tentorium cerebelli, and 3 with DAVF in the craniocervical junction as extra-sinusal type DAVF and 3 with DAVF in the transverse sigmoid sinus and 2 with DAVF in the superior sagittal sinus as DAVF with PLMVD. This type appears to take a very aggressive course. The arterial pressure of the shunt is directly applied to LMV, which causes bending and winding of the vein, eventually varices, inducing intracranial haemorrhage or venous ischemia in the LMV reflux area. Emergency treatment should be performed as soon as possible. Although it is recognized that interruption of the draining vein is very effective, treatment methods such as TAE, direct surgery, and g knife treatment, or their combinations should be carefully chosen for each case.

Entities:  

Year:  2008        PMID: 20587288      PMCID: PMC3490160          DOI: 10.1177/15910199040100S122

Source DB:  PubMed          Journal:  Interv Neuroradiol        ISSN: 1591-0199            Impact factor:   1.610


  14 in total

1.  Combining endovascular and neurosurgical treatments of high-risk dural arteriovenous fistulas in the lateral sinus and the confluence of the sinuses.

Authors:  K Goto; P Sidipratomo; N Ogata; T Inoue; H Matsuno
Journal:  J Neurosurg       Date:  1999-02       Impact factor: 5.115

2.  Hemodynamic and metabolic disturbances in patients with intracranial dural arteriovenous fistulas: positron emission tomography evaluation before and after treatment.

Authors:  T Iwama; N Hashimoto; Y Takagi; M Tanaka; S Yamamoto; S Nishi; K Hayashida
Journal:  J Neurosurg       Date:  1997-05       Impact factor: 5.115

3.  Nontoxic embolic liquids for treatment of arteriovenous malformations.

Authors:  K Kazekawa; H Iwata; T Shimozuru; K Sampei; N Sakaki; N Morikawa; S Matsuda; Y Ikada
Journal:  J Biomed Mater Res       Date:  1997

4.  Surgical interruption of leptomeningeal drainage as treatment for intracranial dural arteriovenous fistulas without dural sinus drainage.

Authors:  M Collice; G D'Aliberti; G Talamonti; V Branca; E Boccardi; G Scialfa; P P Versari
Journal:  J Neurosurg       Date:  1996-05       Impact factor: 5.115

5.  Tortuous, engorged pial veins in intracranial dural arteriovenous fistulas: correlations with presentation, location, and MR findings in 122 patients.

Authors:  R Willinsky; M Goyal; K terBrugge; W Montanera
Journal:  AJNR Am J Neuroradiol       Date:  1999 Jun-Jul       Impact factor: 3.825

6.  [rCBF study with 123I-IMP SPECT of dural arteriovenous fistula].

Authors:  T Kawaguchi; T Kawano; Y Kaneko; T Ooasa; M Tsutsumi; S Ogasawara
Journal:  No To Shinkei       Date:  2000-11

7.  Classification of venous ischaemia with MRI.

Authors:  T Kawaguchi; T Kawano; Y Kaneko; T Ooasa; M Tsutsumi; S Ogasawara
Journal:  J Clin Neurosci       Date:  2001-05       Impact factor: 1.961

8.  Grading venous restrictive disease in patients with dural arteriovenous fistulas of the transverse/sigmoid sinus.

Authors:  A K Lalwani; C F Dowd; V V Halbach
Journal:  J Neurosurg       Date:  1993-07       Impact factor: 5.115

9.  Neurological manifestations of intracranial dural arteriovenous malformations.

Authors:  P Lasjaunias; M Chiu; K ter Brugge; A Tolia; M Hurth; M Bernstein
Journal:  J Neurosurg       Date:  1986-05       Impact factor: 5.115

10.  Cerebral dural arteriovenous fistulas: clinical and angiographic correlation with a revised classification of venous drainage.

Authors:  C Cognard; Y P Gobin; L Pierot; A L Bailly; E Houdart; A Casasco; J Chiras; J J Merland
Journal:  Radiology       Date:  1995-03       Impact factor: 11.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.